Dual-View
![]() |
FDA Safety Changes: Apidra, Ontak, Raptiva
The FDA has approved revisions to the safety labeling for insulin glulisine [rDNA origin] injection (Apidra), denileukin diftitox (Ontak), and efalizumab (Raptiva).
Medscape Medical News
Metabolic Syndrome May Predict Depressive Symptoms
In a prospective cohort study, metabolic syndrome, particularly the obesity and dyslipidemia components, predicted depressive symptoms.
Medscape Medical News
FDA Approves Tramadol Extended-Release Formulation for Chronic Pain
Labopharm, Inc announced the FDA has approved a once-daily extended release formulation of tramadol (Ryzolt) for the management of moderate to moderately severe chronic pain.
Medscape Medical News
Copyright © 2009 ImsForum2004
